Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Xu

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Epidemiology and Population Health|July 6, 2024
Validated administrative data based ICD-10 algorithms for chronic conditions: A systematic reviewAngela Kuang, Claire Xu, Danielle A Southern, et al.
JMIR Research Protocols|February 22, 2023
Design Principles in mHealth Interventions for Sustainable Health Behavior Changes: Protocol for a Systematic ReviewLin Yang, Angela Kuang, Claire Xu, et al.
Open Forum Infectious Diseases|July 31, 2023
Safety, Virology, Pharmacokinetics, and Clinical Experience of High-Dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-Label Clinical TrialJaynier Moya, Marisol Temech, Sergio Parra, et al.
Nature Communications|June 21, 2016
Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancerYujun Hao, Yardena Samuels, Qingling Li, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Epidemiology and Population Health|July 6, 2024
Validated administrative data based ICD-10 algorithms for chronic conditions: A systematic reviewAngela Kuang, Claire Xu, Danielle A Southern, et al.
JMIR Research Protocols|February 22, 2023
Design Principles in mHealth Interventions for Sustainable Health Behavior Changes: Protocol for a Systematic ReviewLin Yang, Angela Kuang, Claire Xu, et al.
Open Forum Infectious Diseases|July 31, 2023
Safety, Virology, Pharmacokinetics, and Clinical Experience of High-Dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-Label Clinical TrialJaynier Moya, Marisol Temech, Sergio Parra, et al.
Nature Communications|June 21, 2016
Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancerYujun Hao, Yardena Samuels, Qingling Li, et al.
Pageof 1